Renaud Heine

Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe

Carin A. Uyl‐de Groot, Renaud Heine, Marieke Krol et al. · Cancers · 2020 · 70 citations · Full text

Medicine, Oncology, Pharmacology +16

Differences in Treatment Patterns and Outcomes of Acute Myocardial Infarction for Low- and High-Income Patients in 6 Countries

Bruce E. Landon, Laura A. Hatfield, Pieter Bakx et al. · JAMA · 2023 · 65 citations · Full text

Medicine, Cardiology, Geriatric Medicine +17

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future

Renaud Heine, Frederick W. Thielen, Marc Koopmanschap et al. · HemaSphere · 2021 · 51 citations · Full text

Pharmacy, Hematology, Oncology +17

Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries: cross sectional cohort study

Peter Cram, Laura A. Hatfield, Pieter Bakx et al. · BMJ · 2022 · 28 citations · Full text

Medicine, Cardiology, Surgery +15

Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma

Frederick W. Thielen, Renaud Heine, Sibren van den Berg et al. · Cytotherapy · 2022 · 26 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +17